Pharnext SCA
OTC:PNEXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharnext SCA
OTC:PNEXF
|
FR |
|
B
|
Bajaj Finance Ltd
BSE:500034
|
IN |
|
M
|
Mena Transport PCL
SET:MENA
|
TH |
|
Journey Medical Corp
NASDAQ:DERM
|
US |
|
Kennametal Inc
NYSE:KMT
|
US |
|
SIG Group AG
OTC:SCBGF
|
CH |
|
10X Genomics Inc
F:1KJ
|
US |
|
C
|
CarGurus Inc
F:0C6
|
US |
|
Gartner Inc
NYSE:IT
|
US |
|
F
|
Fleetcor Technologies Inc
NYSE:CPAY
|
US |
|
E
|
EVI Industries Inc
AMEX:EVI
|
US |
|
XOMA Corp
NASDAQ:XOMA
|
US |
Bankruptcy Probability
Pharnext SCA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Pharnext SCA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Summit Therapeutics Inc
NASDAQ:SMMT
|
11.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Abivax SA
PAR:ABVX
|
6.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Cellectis SA
PAR:ALCLS
|
191m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Innate Pharma SA
PAR:IPH
|
144.3m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SA
PAR:ALPHA
|
1.2k EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
401.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Pharnext SCA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Pharnext SCA has total debt of 24.3m EUR. This includes both short-term (0 EUR) and long-term (24.3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
